Taro Pharmaceutical Industries News
Taro Pharmaceutical Industries Ltd. announced today that it plans to release its financial results for the quarter and year ended March 31, 2013 after market
Antibodies Show Higher Probability of Success and a Higher Rate of M&A: Learn Which Antibody Companies Show the Better Risk/Reward in this Exclusive Interview with The Wall Street TranscriptMay 3
Taro Pharmaceutical Industries Ltd. reported today that it has received approval from the U.S. Food and Drug Administration for its New Drug Applicati
New Product Development and Pipelines in Smaller Medical Devices Companies: Less European Exposure Results in More Limited Exposure to Downside Risk in Those Troubled Countries Across the AtlanticMar 18
Shareholders will no longer have to accept a 24% haircut on their shares.